ReviewMolecular biology reports2026
Programmed cell death in adenomyosis: mechanisms and future perspectives.
Review in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Adenomyosis (ADM) is a common gynecological condition defined by the atypical invasion of endometrial-like structures, including glands and stroma, into the myometrium. ADM has been attributed to many etiologies, with substantial evidence supporting genetic, immunological, mechanical, and hormonal factors. Programmed cell death (PCD) is a distinct form of cell death, distinct from accidental cell death, and is characterized by specialized signaling pathways mediated by specific molecules. The normal process of cell death is essential for maintaining internal homeostasis and serves as a protective mechanism against biological or chemical harm. Numerous recent studies indicate that the progression of ADM is intricately associated with PCD pathways, including apoptosis, autophagy, pyroptosis, and ferroptosis. However, the functions of PCD in ADM have not been reviewed. This article summarizes recent advances and attributes of diverse forms of PCD in the initiation and alleviation of ADM. Investigating PCD in relation to ADM presents significant opportunities for future progress. A thorough understanding of the PCD mechanism in ADM could facilitate the development of innovative therapeutic approaches and delineate future research trajectories in the field.
Indexed as
Identifiers
42606793What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.